We are dedicated to using our expertise, innovation, and precision to unravel the mysteries of tumor diseases.
To unlock the mysteries of cancer, we are dedicated to combining our expertise, ranging from biomedical methodology research in theoretical physics to molecular experiments in biochemistry and medicine. Based on more than a decade of high-impact interdisciplinary research in these fields at two German universities, we propose to the German Federal Ministry of Education and Research (BMBF) the establishment of a bi-national Core of Excellence with our Ukrainian partners.
MAMM will initially transfer knowledge and technology from Germany to Ukraine to implement a permanent Core of Excellence. This will elevate Ukrainian science in this transdisciplinary field into the modern age. For translation into Ukrainian hospitals and commercial exploitation, MAMM will realize the foundation for state-of-the-art sequencing-based cancer diagnostics.
Prof. Dr. Georg Lenz is a trained Hematologist and Oncologist and he is the Director of the “Medical Department A for Hematology, Oncology and Pneumology” at the University of Münster. His main expertise is the identification of molecular lymphoma subtypes and the therapeutic exploitation of oncogenic signaling pathways in hematological malignancies.
Dr. Michael Grau is a trained physicist and computer scientist and he leads the biostatistical team in the group of Prof. Dr. med. Georg Lenz. His main expertise is the de-novo dissection of complex datasets like gene expression or next generation sequencing data to discover novel molecular cancer subtypes and new oncogenic addictions.
Prof. Dr. Peter Lenz has been a professor of theoretical physics in the field of physics at the Philipps-Universität Marburg since 2002. He is an expert in modeling complex systems at the interface of biology and physics. His current research focuses on AI and physical methods-based approaches for investigating high-throughput data in the field of cancer research.
Prof. Dr. Lyubomyr Nykyruy is head of the Physics and Chemistry of Solids department in PNU. He will be a manager and supervisor of PNU activities within the project, and will also be responsible for development and implementation of medical physics research and teaching modules for MAMM.
Prof. Dr. Ruslan Zapukhlyak is Vice-rector of PNU. He is a trained physicist and computer scientist. His expertise is related to testing of possible hardware-implemented algorithms (FPGA) development for rapid analysis of genomic data at the physics department in collaboration with the bioinformatics department of PNU. He will advise for DevOps and IT infrastructure.
Bohdana Naidych is a Ph.D. in Physics, Assistant Professor, Senior Researcher in the Physics and Chemistry of Solid State department at the Vasyl Stefanyk Precarpathian National University. Her research expertise focuses on the application of spatial modeling, data processing, and statistical analysis of complex systems through spatial transcriptomic technology for characterization of particular features of gene expression data.
Oksana Kostiuk, a PhD in Physics and scientific researcher in the Physics and Chemistry of Solid State department at PNU, is highly skilled in mathematics and physics with a strong analytical and critical thinking ability. She has extensive experience in data analysis, modeling, and simulation, and will be responsible for developing methods to identify bi-omic disease signatures for more specific subtyping.
Prof. Dr. Annalen Bleckmann is a trained Hematologist and Oncologist. She holds the position of director of the West German Cancer Center (WTZ) Münster and is Head of the Department "Medical Oncology" at University of Münster. Her scientific expertise includes the treatment of solid tumors with a focus on lung cancer as well as bioinformatics analysis.
Prof. Dr. Stephan Hailfinger is a trained biochemist and heads the “Translational Oncology” department at the University of Münster. His main expertise is the molecular identification and characterization of deregulated signaling pathways in hematological malignancies.
Dr. Kerstin Menck holds a PhD in Molecular Medicine and leads a junior research group at the University of Münster. She is an expert in the analysis and functional characterization of intra- and extracellular signaling pathways implicated in metastasis of solid tumors.
Dr. Corinna Kosnopfel graduated in molecular medicine and is a junior group leader at the UHM. Her expertise centers on the identification and characterization of molecular drivers in tumor pathogenesis along with their exploitation as novel therapeutic target structures and prognostic biomarkers.
Dr. Anja Schmitt holds a PhD in biochemistry and is a junior group leader in the department of translational oncology at the UHM. Her main expertise lies in the identification and molecular characterization of targetable cancer cell vulnerabilities to develop novel therapeutic strategies in hematological malignancies.
Ministry of Education and Science of Ukraine
Ministry of Health of Ukraine
MathWorks
National Cancer Institute of Ukraine, Kyiv, Ukraine
Ivano-Frankivsk Regional State Administration
Ivano-Frankivsk Regional Clinical Hospital, Ukraine
Scientific Park "Precarpathian University", Ivano-Frankivsk, Ukraine